Literature DB >> 26162941

Preoperative anemia is associated with increased use of hospital resources in patients undergoing elective hepatectomy.

May C Tee1, Christopher R Shubert2, Daniel S Ubl3, Elizabeth B Habermann3, David M Nagorney4, Florencia G Que1.   

Abstract

BACKGROUND: In patients undergoing elective hepatectomy, we aimed to evaluate the effect of preoperative anemia on postoperative mortality, morbidity, readmission, risk of blood transfusion, and duration of hospital stay.
METHODS: A total of 4,170 patients who underwent elective hepatectomy from 2010 to 2012 were identified in the American College of Surgeons National Surgical Quality Improvement Program. Univariate and multivariate analyses were performed by examination of the association of preoperative anemia (defined as hematocrit <5) and the risk of any perioperative blood transfusion (defined as ≥1 unit of blood within 72 hours of operation), mean duration of stay, prolonged duration of stay (defined as ≥9 days, which represented the 75th percentile of this cohort), 30-day readmission, major morbidity, and mortality.
RESULTS: A total of 948 patients had preoperative anemia (22.7%). Preoperative anemia was associated with increased risk of any perioperative blood transfusion, prolonged duration of stay, major postoperative complication, and 30-day mortality (P < .05 for all analyses). After controlling for potentially confounding covariates, there was nearly a 3-fold greater risk of blood transfusion (adjusted OR = 2.79, P < .001) and 2-fold greater risk of prolonged duration of stay in anemic versus nonanemic patients (adjusted OR = 1.66, P < .001). Mean duration of stay was 10.0 days and 7.4 days for anemic and nonanemic patients, respectively (P < .001).
CONCLUSION: Anemia is associated with an almost 3-fold increased risk of blood transfusion, 2-fold increased risk of prolonged duration of hospitalization, and hospital stays were 2.6 days greater in anemic patients. Anemia may significantly impact resource utilization for elective hepatectomy.
Copyright © 2015 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2015        PMID: 26162941     DOI: 10.1016/j.surg.2015.06.004

Source DB:  PubMed          Journal:  Surgery        ISSN: 0039-6060            Impact factor:   3.982


  6 in total

1.  The Impact of Increasing Hospital Volume on 90-Day Postoperative Outcomes Following Pancreaticoduodenectomy.

Authors:  Daniel J Kagedan; Nik Goyert; Qing Li; Lawrence Paszat; Alexander Kiss; Craig C Earle; Paul J Karanicolas; Alice C Wei; Nicole Mittmann; Natalie G Coburn
Journal:  J Gastrointest Surg       Date:  2017-01-05       Impact factor: 3.452

2.  Blood transfusion is an independent predictor of morbidity and mortality after hepatectomy.

Authors:  Allison N Martin; Matthew J Kerwin; Florence E Turrentine; Todd W Bauer; Reid B Adams; George J Stukenborg; Victor M Zaydfudim
Journal:  J Surg Res       Date:  2016-07-15       Impact factor: 2.192

3.  Improving the treatment of pre-operative anemia in hepato-pancreato-biliary patients: a quality improvement initiative.

Authors:  Terry M Zwiep; Richard W D Gilbert; Husein Moloo; Donna Touchie; Guillaume Martel; Tom Wallace; Kimberly A Bertens
Journal:  Patient Saf Surg       Date:  2020-04-24

4.  Prediction of perioperative outcome after hepatic resection for pediatric patients.

Authors:  Jianxia Liu; Yunfei Zhang; Hai Zhu; Lin Qiu; Chunbao Guo
Journal:  BMC Gastroenterol       Date:  2019-11-27       Impact factor: 3.067

5.  It is not NOD2 - genetic and clinical risk factors for postoperative complications following ileocolic resection in Crohn's disease.

Authors:  Josefine Schardey; Sophie Zehl; Alina S Kappenberger; Petra Zimmermann; Florian Beigel; Tobias S Schiergens; Michael S Kasparek; Florian Kühn; Jens Werner; Ulrich Wirth
Journal:  Int J Colorectal Dis       Date:  2022-08-01       Impact factor: 2.796

6.  Perioperative outcome of elderly versus younger patients undergoing major hepatic or pancreatic surgery.

Authors:  Qiang Lu; Jian-Wen Lu; Zheng Wu; Xue-Min Liu; Jian-Hui Li; Jian Dong; Guo-Zhi Yin; Yi Lv; Xu-Feng Zhang
Journal:  Clin Interv Aging       Date:  2018-01-24       Impact factor: 4.458

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.